selected publications
-
Metastatic pancreatic neuroendocrine tumors feature elevated T cell infiltration.
JCI insight.
2022
Academic Article
GET IT
Times cited: 3 - Low-dose carbon monoxide suppresses metastatic progression of disseminated cancer cells. Cancer letters. 2022 Academic Article GET IT
-
RHAMMB-mediated bifunctional nanotherapy targeting Bcl-xL and mitochondria for pancreatic neuroendocrine tumor treatment.
Molecular therapy oncolytics.
2021
Academic Article
GET IT
Times cited: 5 -
High levels of truncated RHAMM cooperate with dysfunctional p53 to accelerate the progression of pancreatic cancer.
Cancer letters.
2021
Academic Article
GET IT
Times cited: 12 -
LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer.
Breast cancer research and treatment.
2020
Academic Article
GET IT
Times cited: 5 -
Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer.
Breast cancer research and treatment.
2019
Academic Article
GET IT
Times cited: 22 -
Combined bazedoxifene and paclitaxel treatments inhibit cell viability, cell migration, colony formation, and tumor growth and induce apoptosis in breast cancer.
Cancer letters.
2019
Academic Article
GET IT
Times cited: 26 -
Blocking IL-6/GP130 Signaling Inhibits Cell Viability/Proliferation, Glycolysis, and Colony Forming Activity in Human Pancreatic Cancer Cells.
Current cancer drug targets.
2019
Academic Article
GET IT
Times cited: 17 -
Blocking interleukin-6 signaling inhibits cell viability/proliferation, glycolysis, and colony forming activity of human medulloblastoma cells.
International journal of oncology.
2017
Academic Article
GET IT
Times cited: 24 -
Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy.
PloS one.
2017
Academic Article
GET IT
Times cited: 32 -
Recent advances in biotechnological applications of alcohol dehydrogenases.
Applied microbiology and biotechnology.
2017
Information Resource
GET IT
Times cited: 96 -
Efficient biosynthesis of ethyl (R)-4-chloro-3-hydroxybutyrate using a stereoselective carbonyl reductase from Burkholderia gladioli.
BMC biotechnology.
2016
Academic Article
GET IT
Times cited: 20 -
Chemoenzymatic synthesis of (S)-duloxetine using carbonyl reductase from Rhodosporidium toruloides.
Bioorganic chemistry.
2016
Academic Article
GET IT
Times cited: 21 -
Asymmetric synthesis of optically active methyl-2-benzamido-methyl-3-hydroxy-butyrate by robust short-chain alcohol dehydrogenases from Burkholderia gladioli.
Chemical communications (Cambridge, England).
2015
Academic Article
GET IT
Times cited: 18 -
Stereoselective determination of 2-benzamidomethyl-3-oxobutanoate and methyl-2-benzoylamide-3-hydroxybutanoate by chiral high-performance liquid chromatography in biotransformation.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2014
Academic Article
GET IT
Times cited: 4 -
Syntheses, characterization and antitumor activities of transition metal complexes with isoflavone.
Journal of inorganic biochemistry.
2009
Academic Article
GET IT
Times cited: 39 -
Simultaneous determination of five toxic alkaloids in body fluids by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2008
Academic Article
GET IT
Times cited: 32